Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
0.9300
-0.4400 (-32.12%)
At close: Aug 14, 2026, 4:00 PM EDT
0.8995
-0.0305 (-3.28%)
After-hours: Aug 14, 2026, 7:59 PM EDT
Daré Bioscience Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 12.62 | 24.71 | 15.7 | 10.48 | 34.67 | 51.67 |
Cash & Short-Term Investments | 12.62 | 24.71 | 15.7 | 10.48 | 34.67 | 51.67 |
Cash Growth | 150.60% | 57.42% | 49.85% | -69.78% | -32.91% | 1006.64% |
Other Receivables | 0.46 | 0.57 | 0.23 | 0.95 | 1.7 | 1.15 |
Receivables | 0.46 | 0.57 | 0.23 | 0.95 | 1.7 | 1.15 |
Prepaid Expenses | 2.78 | 1.39 | 2.52 | 6.12 | 6.67 | 2.48 |
Other Current Assets | 0.84 | 0.39 | - | - | - | - |
Total Current Assets | 16.69 | 27.06 | 18.45 | 17.54 | 43.04 | 55.3 |
Property, Plant & Equipment | 3.13 | 4.4 | 2.54 | 1.98 | 0.52 | 0.24 |
Long-Term Deferred Charges | - | - | - | - | - | 0.14 |
Other Long-Term Assets | 2.55 | 1.01 | 1.11 | 1.76 | 0.26 | 0.13 |
Total Assets | 22.37 | 32.47 | 22.1 | 21.28 | 43.83 | 55.81 |
Accounts Payable | 0.76 | 1.2 | 1.46 | 3.39 | 2.03 | 2.1 |
Accrued Expenses | 0.45 | 0.73 | 3.04 | 2.89 | 10.89 | 3.14 |
Current Portion of Long-Term Debt | - | 0.01 | 0 | - | - | - |
Current Portion of Leases | 0.74 | 2.1 | 0.55 | 0.47 | 0.4 | 0.27 |
Current Unearned Revenue | 14.95 | 19.65 | 16.56 | 13.74 | 18.3 | 10.54 |
Other Current Liabilities | 0.01 | - | - | - | - | - |
Total Current Liabilities | 16.92 | 23.69 | 21.61 | 20.48 | 31.62 | 16.05 |
Long-Term Debt | - | 5.39 | 4.75 | - | - | - |
Long-Term Leases | 0.27 | 0.56 | 0.75 | 0.94 | 0.09 | - |
Long-Term Unearned Revenue | - | - | 1 | 1 | 1 | 1 |
Other Long-Term Liabilities | 5.73 | - | - | 3.91 | - | - |
Total Liabilities | 22.93 | 29.63 | 28.11 | 26.33 | 32.71 | 17.05 |
Common Stock | 0 | 0 | 0 | 0 | 0.01 | 0.01 |
Additional Paid-In Capital | 194.48 | 191.95 | 169.71 | 166.55 | 152.53 | 149.03 |
Retained Earnings | -194.67 | -188.69 | -175.29 | -171.24 | -141.07 | -110.13 |
Comprehensive Income & Other | -0.37 | -0.42 | -0.43 | -0.36 | -0.35 | -0.15 |
Shareholders' Equity | -0.56 | 2.84 | -6.01 | -5.05 | 11.11 | 38.75 |
Total Liabilities & Equity | 22.37 | 32.47 | 22.1 | 21.28 | 43.83 | 55.81 |
Total Debt | 1.02 | 8.05 | 6.05 | 1.4 | 0.49 | 0.27 |
Net Cash (Debt) | 11.6 | 16.66 | 9.65 | 9.07 | 34.18 | 51.4 |
Net Cash Growth | 479.33% | 72.69% | 6.33% | -73.46% | -33.51% | 1213.79% |
Net Cash Per Share | 0.82 | 1.49 | 1.14 | 1.25 | 4.85 | 10.09 |
Filing Date Shares Outstanding | 15.29 | 14.56 | 8.85 | 8.38 | 7.18 | 7 |
Total Common Shares Outstanding | 15.17 | 14.5 | 8.7 | 8.33 | 7.07 | 7 |
Working Capital | -0.24 | 3.38 | -3.17 | -2.94 | 11.41 | 39.24 |
Book Value Per Share | -0.04 | 0.20 | -0.69 | -0.61 | 1.57 | 5.54 |
Tangible Book Value | -0.56 | 2.84 | -6.01 | -5.05 | 11.11 | 38.75 |
Tangible Book Value Per Share | -0.04 | 0.20 | -0.69 | -0.61 | 1.57 | 5.54 |
Machinery | - | 1.86 | 0.24 | 0.16 | - | - |
Construction In Progress | - | - | 1.23 | 0.6 | - | - |
Leasehold Improvements | - | 0.04 | 0.04 | 0.04 | - | - |